NYSE:CNCHealthcare
Reassessing Centene (CNC) Valuation After ACA Subsidy Uncertainty and Legal Scrutiny on 2025 Outlook
Centene (CNC) is back in the spotlight after a sharp selloff tied to two pressure points: fresh doubts over Affordable Care Act subsidies and new legal scrutiny of its withdrawn 2025 outlook.
See our latest analysis for Centene.
That backdrop helps explain why, despite a solid 90 day share price return of 19.14% from a recent low, Centene’s year to date share price return of negative 35.51% and three year total shareholder return of negative 52.20% show momentum has been fragile rather than...